ALTERITY THERAPEUTICS LTD (ATHE) has 4 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $48K. Most recent filing: Sept. 8, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 8, 2026 filed Aug. 31, 2026 | Marks Peter Ashley Director | +$47,620 | 95,240 | — | No | |
|
|
||||||
| Sept. 8, 2026 filed Aug. 31, 2026 | Stamler David Allen Chief Executive Officer | $23,810 | 47,620 | — | No | |
|
|
||||||
| June 23, 2026 filed June 15, 2026 | Babarczy Julian Michael Director | $0 | 2,000,000 | 0% | No | |
|
|
||||||
| June 23, 2026 filed June 15, 2026 | Gozlan Lawrence Bernard Director | $0 | 1,000,000 | 0% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free